Corneal Ulcer Clinical Trial
Penetrating keratoplasty (PKP) is an open-sky surgery that fundamentally has not changed for more than 100 years. Because conventional PKP is associated with the potential for the development of devastating complications such as expulsive suprachoroidal hemorrhage and endophthalmitis, we modified the technique to one that is a closed surgery under topical anesthesia with the anterior chamber maintained to achieve favorable results. Topical anesthesia is an attractive alternative to traditional injection local anesthesia since the potentially serious complications associated with retrobulbar and peribulbar anesthesia can be avoided. The closed PKP procedure with the stable anterior chamber essentially changes the open nature of conventional PKP. The advantages, i.e., decreased surgical risks, postoperative complications, and surgical difficulties, make PKP viable in most complicated cases.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | December 2016 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 90 Years |
Eligibility |
Inclusion Criteria: - active bacterial keratitis, for which ulceration progressed despite maximum antibacterial medication; - refractory fungal keratitis that did not respond to antifungal agents; - nonactive HSK, for which corneal opacities with or without new vessels involved the optical zone; - ocular acid burn and thermal burn with partial limbal deficiency (50% or less) that, after more than half a year of preoperative treatment, showed reepithelialization and less than 2 quadrants limbal neovascularization. Exclusion Criteria: - Patients with keratolimbal allograft transplantation, total limbal stem cell deficiency secondary to ocular burns, and other ocular diseases (ie, amblyopia, age-related cataract, glaucoma, macular edema, and mac ular degeneration) were excluded. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
China | Eye Hospital, Wenzhou Medical College | Wenzhou | Zhejiang |
Lead Sponsor | Collaborator |
---|---|
Wenzhou Medical University |
China,
Chen W, Ren Y, Zheng Q, Li J, Waller SG. Securing the anterior chamber in penetrating keratoplasty: an innovative surgical technique. Cornea. 2013 Sep;32(9):1291-5. doi: 10.1097/ICO.0b013e31829954c5. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | best corrected visual acuity | preoperative | Yes | |
Primary | best corrected visual acuity | 1 week after PKP | Yes | |
Primary | best corrected visual acuity | 2 weeks after PKP | Yes | |
Primary | best corrected visual acuity | 1 month after PKP | Yes | |
Primary | best corrected visual acuity | 3 months after PKP | Yes | |
Primary | best corrected visual acuity | 6 months after PKP | Yes | |
Secondary | Endothelial cell density | 1 week after PKP | Yes | |
Secondary | Endothelial cell density | 2 weeks after PKP | Yes | |
Secondary | Endothelial cell density | 1 month after PKP | Yes | |
Secondary | Endothelial cell density | 3 months after PKP | Yes | |
Secondary | Endothelial cell density | 6 months after PKP | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05705024 -
Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells
|
Phase 2 | |
Completed |
NCT02731638 -
Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers
|
Phase 3 | |
Completed |
NCT00324168 -
Steroids for Corneal Ulcers Trial
|
Phase 4 | |
Completed |
NCT04484402 -
Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells
|
Phase 1/Phase 2 | |
Completed |
NCT04820010 -
Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3
|
||
Recruiting |
NCT02570321 -
Cross-linking for Corneal Ulcers Treatment Trial
|
Phase 4 | |
Completed |
NCT00386958 -
A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers
|
Phase 2 | |
Completed |
NCT04054817 -
ACRO Biocornea Clinical Trial in Taiwan
|
N/A | |
Completed |
NCT00997035 -
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
|
Phase 3 | |
Completed |
NCT02277054 -
Safety and Effectiveness of Collagen-phosphorylcholine Bioengineered Cornea in Patients Requiring Lamellar Keratoplasty
|
N/A | |
Recruiting |
NCT05313828 -
Effect of Various Treatment Modalities on Dendritic Vial Ulcer
|
||
Recruiting |
NCT05255107 -
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
|
Phase 2/Phase 3 | |
Recruiting |
NCT05255016 -
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
|
Phase 2/Phase 3 | |
Completed |
NCT05891106 -
AONDA Therapeutic Indication Study I
|
||
Terminated |
NCT00789646 -
Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients
|
N/A | |
Not yet recruiting |
NCT05940376 -
Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy
|
||
Completed |
NCT05200000 -
Wharton's Jelly Eye Drops in the Treatment of Chronic Keratitis
|
Phase 1 | |
Completed |
NCT01756456 -
Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01969786 -
Village Integrated Eye Workers Trial
|
N/A | |
Completed |
NCT01794312 -
Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer
|
Phase 3 |